FindTrial
Sign In

To Study Colorectal Adenocarcinoma

Study of Tumour Budding in Colorectal Adenocarcinoma and its association with pathologic prognostic parameters - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062722
Enrollment
40
Registered
2024-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor
DrShivali Kalode
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patients whose colectomy specimen will be received to the sections of surgical pathology. 2.The patients with histopathological diagnosis of adenocarcinoma of colorectum on the specimen of colectomy.

Exclusion criteria

Exclusion criteria: 1.The patients who will be diagnosed adenocarcinoma of colorectum on biopsy. 2. The patients who will be diagnosed as adenocarcinoma of colorectum and lacks the required clinical details.

Design outcomes

Primary

MeasureTime frame
Association of pathological prognostic marker with Tumor Budding in Colorectal AdenocarcinomaTimepoint: 12 WEEKS—

Secondary

MeasureTime frame
Assessement of tumour budding in colorectal adenocarcinomaTimepoint: 2 years—

Countries

India

Contacts

Public Contactdrshivali sudhakar kalode

Datta meghe institute of medical sciences

aravani@rediff.com9822684255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026